Danny Sullivan

Contributing Editor

Preston's Summary

Danny Sullivan is a Contributing Editor for Longevity.Technology, where he covers the latest developments in longevity research and technology. With a focus on biotech and healthcare, Danny provides insightful coverage of companies, clinical trials, and breakthroughs in the field of longevity, highlighting the potential impact on human health and well-being.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

United States (National)

Coverage Attributes:

Beta
Press Release: 52 %
Private Sector Announcements: 22 %
Cites Data: 13 %
Event Coverage: 3 %
Industry Specific: 2 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Aging & Longevity
  • Gene Therapy
  • Public Health

Pitching Insights

Danny Sullivan's coverage primarily focuses on healthcare, pharmaceuticals, and scientific advancements related to longevity research, biotechnology, aging, and medical breakthroughs. His articles often include press releases and private sector announcements.

To effectively reach out to Danny Sullivan, consider providing information about new developments in the aforementioned fields or offering interviews with key figures from relevant companies or organizations involved in these areas. Additionally, if there are specific data-driven insights or analyses related to longevity research or healthcare funding that can contribute to his coverage themes, those would likely be of interest as well.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Most recent topics
Not enough data
Most recent topics
Not enough data
Most recent topics
Not enough data